Matkowska-Kocjan, A.; Owoc-Lempach, J.; Chruszcz, J.; Kuźnik, E.; Szenborn, F.; Jurczenko, L.; Wójcik, M.; Banyś, D.; Szenborn, L.; Ussowicz, M.
The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation. Vaccines 2021, 9, 1209.
https://doi.org/10.3390/vaccines9101209
AMA Style
Matkowska-Kocjan A, Owoc-Lempach J, Chruszcz J, Kuźnik E, Szenborn F, Jurczenko L, Wójcik M, Banyś D, Szenborn L, Ussowicz M.
The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation. Vaccines. 2021; 9(10):1209.
https://doi.org/10.3390/vaccines9101209
Chicago/Turabian Style
Matkowska-Kocjan, Agnieszka, Joanna Owoc-Lempach, Joanna Chruszcz, Edwin Kuźnik, Filip Szenborn, Lidia Jurczenko, Marta Wójcik, Dorota Banyś, Leszek Szenborn, and Marek Ussowicz.
2021. "The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation" Vaccines 9, no. 10: 1209.
https://doi.org/10.3390/vaccines9101209
APA Style
Matkowska-Kocjan, A., Owoc-Lempach, J., Chruszcz, J., Kuźnik, E., Szenborn, F., Jurczenko, L., Wójcik, M., Banyś, D., Szenborn, L., & Ussowicz, M.
(2021). The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation. Vaccines, 9(10), 1209.
https://doi.org/10.3390/vaccines9101209
